showed 10.6% sensitivity, 100% specificity compared to 36% sensitivity, 86% specificity of manual cytology and 93% sensitivity, 50.0% specificity of manual cytology (cell block). ClearCyte TM automated quantitative image cytometry showed 100% specificity for diagnosis of NSCLC, adenocarcinoma, and SCLC.
tive image cytometry were positive for atypical cells in 5 out of the 112 specimens, negative for 71, and no detectable analyzable epithelial cells in 36 cases. ClearCyte TM automated quantitative image cytometry showed 10.6% sensitivity, 100% specificity compared to 36% sensitivity, 86% specificity of manual cytology and 93% sensitivity, 50.0% specificity of manual cytology (cell block). ClearCyte TM automated quantitative image cytometry showed 100% specificity for diagnosis of NSCLC, adenocarcinoma, and SCLC. Results: A total of 117 patients with the diagnosis of lung cancer died in our hospital were analyzed. Of them, 26 (22.2%) patients received MV and 91 (77.8%) patients received non-invasive respiratory care (7 received NIV and 84 received O 2 therapy). Up to 45.2 % patients received anticancer therapies before death. The duration of hospital stay was relatively longer in patients received MV (26.6 vs 22.4, P = 0.384). Patients with smoking history, better performance status (ECOG:0-1), malignant pleural effusion and multiple metastatic sites had higher risk of intubation at EOL. In contrast, patients with hospice care before last admission had lower risk of intubation (47.3% vs 11.5%, P = 0.001). Multi-variant analysis showed that patients with poor performance status and prior hospice care were associated with lower risk of intubation before death. (OR:0.104, P = 0.009 and OR:0.113, P = 0.013, respectively).
Conclusion

Conclusion:
Around one-fifth of lung cancer patients died on mechanical ventilation. Prior hospice care and poor performance status were associated with lower risk of MV at EOL for patients with lung cancer. 
